High Dose Nimodipine Treatment Adjunct - 1

This study has been completed.

Sponsor:

Collaborator:

Washington D.C. Veterans Affairs Medical Center

Information provided by:

National Institute on Drug Abuse (NIDA)

ClinicalTrials.gov Identifier:

NCT00000332

First received: September 20, 1999

Last updated: June 2, 2015

Last verified: December 2002

History of Changes

Purpose

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: Nimodipine	Phase 2


Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	High Dose Nimodipine Pharmacotherapy Adjunct

Resource links provided by NLM:

Drug Information available for: Nimodipine

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Stimulated and non-stimulated craving
Stimulated and non-stimulated withdrawal
Anxiety, depression
Heart rate


Estimated Enrollment:	0

Eligibility


Ages Eligible for Study:	22 Years to 45 Years (Adult)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000332

Locations


United States, District of Columbia
Washington DC VA
Washington, District of Columbia, United States, 20422

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Washington D.C. Veterans Affairs Medical Center

Investigators


Principal Investigator:	Steven Deutsch, M.D.	Washington D.C. Veterans Affairs Medical Center

More Information


ClinicalTrials.gov Identifier:	NCT00000332 History of Changes
Other Study ID Numbers:	NIDA-3-0009-1 Y01-3-0009-1
Study First Received:	September 20, 1999
Last Updated:	June 2, 2015
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:


Cocaine-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Nimodipine	Antihypertensive Agents Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Vasodilator Agents

ClinicalTrials.gov processed this record on September 26, 2016

To Top